Collegium Pharmaceutical (COLL) Net Equity Issued and Repurchased (2015 - 2017)

Collegium Pharmaceutical has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $24.9 million in Q4 2017.

• On a quarterly basis, Net Equity Issued and Repurchased fell 70.94% year-over-year to $24.9 million in Q4 2017; TTM through Dec 2017 was $111.1 million, a 19.12% decrease from a year earlier, with the FY2018 full-year figure at -$30000.0, down 100.09% from the prior year.
• Net Equity Issued and Repurchased was $24.9 million for Q4 2017 at Collegium Pharmaceutical, down from $85.7 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $85.7 million in Q4 2016, with the low at $445000.0 in Q3 2016.
• Average Net Equity Issued and Repurchased over 3 years is $42.5 million, with a median of $50.0 million recorded in 2015.
• The sharpest annual moves came in 2016 and 2017: Net Equity Issued and Repurchased gained 2.35% in 2016, then tumbled 70.94% in 2017.
• Over 3 years, Net Equity Issued and Repurchased stood at $50.0 million in 2015, then jumped by 71.44% to $85.7 million in 2016, then sank by 70.94% to $24.9 million in 2017.
• The last three Net Equity Issued and Repurchased figures came in at $24.9 million (Q4 2017), $85.7 million (Q4 2016), and $445000.0 (Q3 2016), per Business Quant data.